NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma

The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent a viable source for anticancer-directed cellular therapies. Immunohistochemistry was used to test the survivin (n = 40 samples) and NY-ESO-1...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Immunol Immunother
Prif Awduron: Liu, Zhenjiang, Poiret, Thomas, Persson, Oscar, Meng, Qingda, Rane, Lalit, Bartek, Jiri, Karbach, Julia, Altmannsberger, Hans-Michael, Illies, Christopher, Luo, Xiaohua, Harvey-Peredo, Inti, Jäger, Elke, Dodoo, Ernest, Maeurer, Markus
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2017
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799356/
https://ncbi.nlm.nih.gov/pubmed/29058035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2066-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg